The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillation

BACKGROUND: The periprocedural protocol for atrial fibrillation (AF) ablation commonly includes anticoagulation therapy. Apixaban, a direct oral anticoagulant, is currently approved for clinical use; however, little is known about the effects of residual apixaban concentration on bleeding complicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukai, Yutaro, Wada, Kyoichi, Miyamoto, Koji, Nakagita, Kazuki, Fujimoto, Mai, Hosomi, Kouichi, Kuwahara, Takeshi, Takada, Mitsutaka, Kusano, Kengo, Oita, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634723/
https://www.ncbi.nlm.nih.gov/pubmed/29021846
http://dx.doi.org/10.1016/j.joa.2017.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634723/
https://www.ncbi.nlm.nih.gov/pubmed/29021846
http://dx.doi.org/10.1016/j.joa.2017.06.005

Ejemplares similares